---
title: "Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296398129.md"
description: "Vertex Pharmaceuticals (VRTX) shares rose 4.52% to $552.06, outperforming competitors on a strong trading day. The stock hit a new 52-week high, marking its third consecutive gain. While the broader market saw modest gains, VRTX's performance stood out against peers like AbbVie and Krystal Biotech, though Arcturus Therapeutics surged significantly. Trading volume remained slightly below the 50-day average."
datetime: "2026-08-19T20:37:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296398129.md)
  - [en](https://longbridge.com/en/news/296398129.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296398129.md)
generator: "portal-rs"
---

# Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. (VRTX) rose 4.52% to $552.06 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.

This was the stock's third consecutive day of gains.

Vertex Pharmaceuticals Inc. hit a new 52-week high, surpassing its previous peak of $546.17, which the company achieved on August 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) rose 2.72% to $265.97, Krystal Biotech Inc. (KRYS) rose 3.16% to $343.34, and Arcturus Therapeutics Holdings Inc. (ARCT) rose 25.21% to $10.28.

Trading volume (1.4 M) remained 170,463 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-19-26 1637ET

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)

## Related News & Research

- [Clal Insurance Enterprises Holdings Ltd Buys Shares of 2,019 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296756674.md)
- [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md)
- [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md)
- [Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296771760.md)
- [TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296021261.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**